Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00869804 · ClinicalTrials.gov registry record · NA
Heading Off Peripheral Neuropathy With Exercise
A NA study, sponsored by University of Nebraska.
- Terminated
- Registry status
- NA
- Development phase
- 19
- Enrollment target
NCT00869804: Clinical Trial NA study, sponsored by University of Nebraska.
NCT00869804 is a NA study that was terminated before completion, run by University of Nebraska. The registered enrollment target is 19 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00869804, a NA study, was terminated before completion, sponsored by University of Nebraska.
- TERMINATED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
Study Summary
Chemotherapy for the treatment of breast cancer can affect nerves and muscles leading to loss of sensation in the hands and feet for feeling hot and cold, difficulty walking, and muscle weakness. This study will explore if exercises such as walking and strength training may prove helpful in preventing or lessening chemotherapy-induced peripheral neuropathy from chemotherapy, making the therapy easier to tolerate and increasing overall quality of life.
Primary Outcome
effect size for reduction of neuropathic symptoms
Interventions
- BEHAVIORAL Attention control
- BEHAVIORAL Aerobic/ Resistance Exercise Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2009-03-25 |
| Est. Completion | 2011-12-13 |
| Phase | NA |
Why NCT00869804 stopped before completion
NCT00869804 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 19 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Attention control is the first listed.
NCT00869804 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00869804 about?
NCT00869804 is a clinical study titled "Heading Off Peripheral Neuropathy With Exercise". Chemotherapy for the treatment of breast cancer can affect nerves and muscles leading to loss of sensation in the hands and feet for feeling hot and cold, difficulty walking, and muscle weakness. This study will explore if exercises such as walking and strength training may prove helpful in preventi...
What is the current status of trial NCT00869804?
This trial is currently terminated. It is a NA study. The enrollment target is 19 participants. The study started on 2009-03-25. Estimated completion is 2011-12-13.
What interventions are being tested in trial NCT00869804?
The interventions under investigation include: Attention control (BEHAVIORAL), Aerobic/ Resistance Exercise Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT00869804?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00869804's enrollment target sits among peer trials
19 1861st of 2000 higher than 138 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03207464 · 19 participants · Phase 1
Molecular Imaging of NET Using [C-11]MRB-PET in MS
- NCT04318717 · 19 participants · Phase 2
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
- NCT05103904 · 19 participants · Phase 2
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
- NCT05607407 · 19 participants · Phase 2
Methimazole in Patients With Progressive Glioblastoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI